Literature DB >> 8254191

Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid.

E J Hansen1, S R Lumbley, J A Richardson, B K Purcell, M K Stevens, L D Cope, J Datte, J D Radolf.   

Abstract

The temperature-dependent rabbit model for chancroid, a sexually transmitted disease caused by the fastidious Gram-negative bacterium Haemophilus ducreyi, was used to investigate the abilities of previous infection and immunization with an acellular preparation of H. ducreyi to induce protective immunity. In the first set of experiments, animals were infected intradermally with either the 35000 or Cha-1 strains of H. ducreyi and then rechallenged 30 days later with both the homologous and heterologous strains. In animals infected with the 35000 strain, statistically significant protective immunity occurred only against the homologous strain, whereas protection against both homologous and heterologous challenge was obtained in rabbits previously infected with strain Cha-1. In a separate series of experiments, rabbits were immunized with cell envelopes from either strain 35000 or strain Cha-1 and then challenged with both the homologous and heterologous strains. In rabbits immunized with strain 35000 cell envelopes, significant protective immunity was observed only against challenge with the homologous strain. In animals immunized with strain Cha-1 cell envelopes, protection was obtained against both homologous and heterologous challenge. Histopathologic analysis of sites inoculated with strain 35000 (10(5) CFU) demonstrated that the inflammatory response in control animals was predominantly suppurative (i.e., heterophilic), whereas that of immunized animals was predominantly mononuclear and, at later time points, largely histiocytic. ELISA and Western blot analyses revealed that immunization produced a better humoral immune response than did infection and provided evidence for antigenic cross-reactivity between these two strains. These results provide the experimental basis for continued efforts to identify potential H. ducreyi vaccinogens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254191

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi.

Authors:  M K Stevens; J Klesney-Tait; S Lumbley; K A Walters; A M Joffe; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

3.  Haemophilus ducreyi infection causes basal keratinocyte cytotoxicity and elicits a unique cytokine induction pattern in an In vitro human skin model.

Authors:  M M Hobbs; T R Paul; P B Wyrick; T H Kawula
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi.

Authors:  K L Thomas; I Leduc; B Olsen; C E Thomas; D W Cameron; C Elkins
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  A system for generalized mutagenesis of Haemophilus ducreyi.

Authors:  M K Stevens; L D Cope; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

6.  Use of tissue culture and animal models to identify virulence-associated traits of Haemophilus ducreyi.

Authors:  M J Alfa; M K Stevens; P DeGagne; J Klesney-Tait; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

7.  In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.

Authors:  Hinda J Ahmed; Catharina Johansson; Liselott A Svensson; Karin Ahlman; Margareta Verdrengh; Teresa Lagergård
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.

Authors:  Merja Vakevainen; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  A humoral immune response confers protection against Haemophilus ducreyi infection.

Authors:  Leah E Cole; Kristen L Toffer; Robert A Fulcher; Lani R San Mateo; Paul E Orndorff; Thomas H Kawula
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease.

Authors:  M Desjardins; L G Filion; S Robertson; D W Cameron
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.